Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.6.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash and Cash Equivalents $ 3,635,224 $ 8,394,133
License and Grant Fees Receivable 37,349 907,500
Prepaid Expenses and Other Current Assets 464,981 122,395
Current Portion of Refundable Tax Credit Receivable 16,484 25,086
Total Current Assets 4,154,038 9,449,114
Property and Equipment, Net 38,040 0
Restricted Cash 45,000 20,000
Goodwill and In-Process R&D 5,438,210 0
Non-Current Assets:    
Other Assets 55,314 38,587
Total Assets 9,730,602 9,507,701
Current Liabilities:    
Accounts Payable 1,412,128 417,697
Accrued Expenses 1,670,930 1,095,738
Deferred Revenue 4,225,000 1,907,500
Total Current Liabilities 7,308,058 3,420,935
Non-Current Liabilities:    
Contingent Consideration 1,210,000 0
Deferred Tax Liability 1,525,896 0
Long-Term Portion of Capital Lease Obligation 16,069 0
Total Non-Current Liabilities 2,751,965 0
Total Liabilities 10,060,023 3,420,935
Commitments and Contingencies (Note 11)
Stockholders’ (Deficit) Equity:    
Preferred Stock, $0.01 Par Value: 9,997,223 and 10,000,000 Shares Authorized at December 31, 2015 and 2016, respectively; 0 Shares Issued and Outstanding at December 31, 2016 and 2015 0 0
Common Stock, $0.01 Par Value: 100,000,000 Shares Authorized; 10,130,883 Shares Issued and Outstanding at December 31, 2016 and 7,657,287 Shares Issued and Outstanding at December 31, 2015 101,309 76,573
Additional Paid-In Capital 78,106,645 71,209,530
Accumulated Deficit (78,598,738) (65,255,301)
Stockholders’ Notes Receivable (58,824) (58,824)
Accumulated Other Comprehensive Income 120,187 114,788
Total Stockholders’ (Deficit) Equity (329,421) 6,086,766
Total Liabilities and Stockholders’ (Deficit) Equity $ 9,730,602 $ 9,507,701